740776

Astellas Pharma US Inc. — FEI 1000036852

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 23, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Northbrook, IL (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)